BACKGROUND: Urinary incontinence significantly affects daily life of suffering women. Minimally invasive solutions to cope with urine leakage would be of great interest. METHODS: A survey to investigate efficacy and compliance of an innovative intravaginal device (Diveen®) to reduce the risk of urine leakage was performed in 5 Urogynecological centers across Italy. Women with urodynamic diagnosis of stress incontinence, included mixed conditions, underwent the survey. RESUlTS: The device was effective (60%) independently from severity of incontinence or the presence of concomitant detrusor overactivity (mixed forms) with a positive impact on quality of life in more than half of the women. also compliance with the device was satisfactory (up to 73%). clinically symptomatic prolapse and age >65 years are the only limiting factors in terms of efficacy and compliance, while the menopausal status would not seem to affect these aspects. CONCLUSIONS: Despite global satisfactory outcomes, 46% of the surveyed women declare their propensity to use the device. This data deserves further investigation.
An innovative device in the management of female urodynamic stress incontinence: A perception survey
Serati M.
2020-01-01
Abstract
BACKGROUND: Urinary incontinence significantly affects daily life of suffering women. Minimally invasive solutions to cope with urine leakage would be of great interest. METHODS: A survey to investigate efficacy and compliance of an innovative intravaginal device (Diveen®) to reduce the risk of urine leakage was performed in 5 Urogynecological centers across Italy. Women with urodynamic diagnosis of stress incontinence, included mixed conditions, underwent the survey. RESUlTS: The device was effective (60%) independently from severity of incontinence or the presence of concomitant detrusor overactivity (mixed forms) with a positive impact on quality of life in more than half of the women. also compliance with the device was satisfactory (up to 73%). clinically symptomatic prolapse and age >65 years are the only limiting factors in terms of efficacy and compliance, while the menopausal status would not seem to affect these aspects. CONCLUSIONS: Despite global satisfactory outcomes, 46% of the surveyed women declare their propensity to use the device. This data deserves further investigation.File | Dimensione | Formato | |
---|---|---|---|
R09Y2020N04A0219.pdf
non disponibili
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
602.42 kB
Formato
Adobe PDF
|
602.42 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.